Reuters Article: Barriers to Latest Alzheimer’s Treatments for Down Syndrome Community
Hampus Hillerstrom, CEO of LuMind IDSC Foundation and father to a child with Down syndrome, knows about the barriers people
October 10, 2023
Hampus Hillerstrom, CEO of LuMind IDSC Foundation and father to a child with Down syndrome, knows about the barriers people
Tuesday, September 26, 2023 NIH designates people with disabilities as a population with health disparities Designation, new research program and
LuMind IDSC and The Arc of Northeast collaborated on an OpEd that was recently published in The Boston Globe. Authors
LuMind IDSC issues statement following FDA full approval of Leqembi™ to treat early-stage Alzheimer’s disease July 7, 2023 In a
Last week the FDA announced a full approval of a new drug called Leqembi to treat Alzheimer’s Disease. The approval
The fact sheets linked below share estimates of the numbers of babies born and people living with Down syndrome in
Study Finds Assistive Technology Has Positive Outcomes for Children with Down Syndrome and Their Caregivers In partnership with the LuMind
Seeking to rectify existing federal and state policies which prevent people with intellectual disabilities from accessing new therapies for Alzheimer’s
Pharmaceutical company Eli Lilly today announced results of a phase III clinical trial that proves their anti-amyloid drug, donanemab, significantly
Have you ever wondered what certain scientific terms or acronyms mean? If you’re interested in the scientific advances working towards